Menu
← Oncology Approval Tracker
FDA DECISION ·
Lenalidomide 2.5 mg (generic Revlimid)
lenalidomide · Dr. Reddy’s Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
FDA lists a first generic Revlimid capsule approval including the 2.5 mg strength for multiple myeloma.
LAMPGEN ANALYSIS
Why it matters
The application adds the 2.5 mg strength to the first-generic record after the May approval of higher strengths.
What research teams should watch
Track strengths individually in formulary review and retain indication-specific dispensing requirements.
PRIMARY RECORDS